PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cold Agglutinin Disease

Sanofi Presents Results of Sutimlimab in P-III CADENZA Trial to Treat Hemolysis Patients with Cold Agglutinin Disease at EHA 2021

Sanofi Presents Results of Sutimlimab in P-III CADENZA Trial to Treat Hemolysis Patients with Cold Agglutinin Disease at EHA 2021

June 14, 2021

Sanofi's Sutimlimab Receives the US FDA's Priority Review to Treat Hemolysis Patients with Cold Agglutinin Disease

Sanofi's Sutimlimab Receives the US FDA's Priority Review to Treat Hemolysis Patients with Cold Agglutinin Disease

May 14, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us